John F Thompson
#96,486
Most Influential Person Now
Researcher
John F Thompson's AcademicInfluence.com Rankings
John F Thompsoncomputer-science Degrees
Computer Science
#3342
World Rank
#3505
Historical Rank
Computer Engineering
#13
World Rank
#13
Historical Rank
Data Science
#28
World Rank
#28
Historical Rank
Computational Linguistics
#151
World Rank
#155
Historical Rank
Download Badge
Computer Science
John F Thompson's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is John F Thompson Influential?
(Suggest an Edit or Addition)John F Thompson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Final version of 2009 AJCC melanoma staging and classification. (2009) (4419)
- Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. (2001) (2651)
- Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. (2001) (2315)
- Genomic Classification of Cutaneous Melanoma (2015) (2143)
- Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual (2017) (1458)
- Sentinel-node biopsy or nodal observation in melanoma. (2006) (1348)
- Final trial report of sentinel-node biopsy versus nodal observation in melanoma. (2014) (1152)
- Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. (2011) (957)
- Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma (2017) (882)
- Whole-genome landscapes of major melanoma subtypes (2017) (875)
- Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. (1999) (779)
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma (2012) (699)
- Porphyry deposits; characteristics and origin of hypogene features (2005) (652)
- Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. (2012) (593)
- Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial (2005) (589)
- Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma (2011) (578)
- Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes (1995) (456)
- BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact (2014) (430)
- A new American Joint Committee on Cancer staging system for cutaneous melanoma (2000) (428)
- An Evidence‐based Staging System for Cutaneous Melanoma 1 (2004) (420)
- Determinants of outcome in melanoma patients with cerebral metastases. (2004) (411)
- Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma (2003) (407)
- Psychological responses of patients receiving a diagnosis of cancer. (2003) (396)
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy. (2019) (393)
- Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma (2012) (392)
- Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. (2010) (389)
- Patterns of somatic structural variation in human cancer genomes (2020) (377)
- PD‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐PD‐1/PD‐L1 clinical trials (2015) (342)
- Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. (2006) (328)
- Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. (2011) (327)
- Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma (2013) (286)
- Mammary lymphoscintigraphy in breast cancer. (1995) (284)
- Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma (2014) (280)
- Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. (1995) (270)
- Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. (1993) (265)
- The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. (1996) (249)
- Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. (2012) (248)
- Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, a (1998) (241)
- CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment (2018) (240)
- Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms. (2015) (240)
- UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas. (2015) (238)
- Experience with 998 cutaneous melanomas of the head and neck over 30 years. (1991) (235)
- Surgical excision margins for primary cutaneous melanoma. (2009) (229)
- Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion. (1998) (215)
- Patterns of lymphatic drainage from the skin in patients with melanoma. (2003) (213)
- Desmoplastic and desmoplastic neurotropic melanoma (1998) (209)
- Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway (2015) (204)
- The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up (2004) (204)
- Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma (2007) (201)
- 100 Multivisceral Transplants at a Single Center (2005) (199)
- Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
- Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. (1999) (195)
- The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I) (2010) (188)
- Noise pollution in the operating theatre (1990) (188)
- EANM-EORTC general recommendations for sentinel node diagnostics in melanoma (2009) (187)
- An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites (2007) (181)
- BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. (2013) (181)
- Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma (2017) (171)
- Positron emission tomography in the detection and management of metastatic melanoma (1996) (169)
- Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I) (2012) (163)
- Interval nodes: the forgotten sentinel nodes in patients with melanoma. (2000) (161)
- Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. (2001) (161)
- Merkel cell polyomavirus status is not associated with clinical course of Merkel cell carcinoma. (2011) (160)
- Interobserver Reproducibility of Histopathologic Prognostic Variables in Primary Cutaneous Melanomas (2003) (155)
- Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. (2015) (155)
- Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets (2019) (155)
- Age as a Prognostic Factor in Patients with Localized Melanoma and Regional Metastases (2013) (150)
- Sentinel node biopsy and standard of care for melanoma. (2009) (149)
- Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial. (2002) (148)
- Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience (2008) (146)
- Activation of CCR9/CCL25 in Cutaneous Melanoma Mediates Preferential Metastasis to the Small Intestine (2008) (144)
- Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care (2011) (138)
- The role of cell cycle regulatory proteins in the pathogenesis of melanoma (2006) (138)
- MORPHOMETRIC ANALYSIS OF CELLULAR INFILTRATION ASSESSED BY MONOCLONAL ANTIBODY LABELING IN SEQUENTIAL HUMAN RENAL ALLOGRAFT BIOPSIES (1986) (138)
- Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma (1994) (137)
- Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients (2017) (136)
- Prognosis for patients with thin cutaneous melanoma (2003) (134)
- Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy. (2011) (133)
- Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination (2015) (133)
- Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. (2004) (129)
- New TNM melanoma staging system: linking biology and natural history to clinical outcomes. (2003) (128)
- Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy (2004) (127)
- Cutaneous melanoma (2005) (127)
- Update on the melanoma staging system: The importance of sentinel node staging and primary tumor mitotic rate (2011) (126)
- Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma (2002) (125)
- Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. (2019) (124)
- Subungual Melanoma: A Study of 124 Cases Highlighting Features of Early Lesions, Potential Pitfalls in Diagnosis, and Guidelines for Histologic Reporting (2007) (123)
- Cutaneous melanoma in the era of molecular profiling (2009) (123)
- Intestinal and Multivisceral Transplantation in Children (2006) (123)
- Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients (2014) (122)
- Correlation Between Preoperative Lymphoscintigraphy and Metastatic Nodal Disease Sites in 362 Patients With Cutaneous Melanomas of the Head and Neck (2004) (122)
- Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. (2001) (122)
- The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. (2005) (122)
- The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. (2014) (122)
- PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor–Treated Melanoma Patients (2015) (121)
- Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study (2006) (121)
- Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy) (2005) (121)
- Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma (2014) (120)
- Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition (2020) (119)
- Rapid Communication: Increased Frequency of TCRγδ+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for Leukemia (1996) (118)
- Prognostic factors in cutaneous desmoplastic melanoma (2010) (118)
- Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma (1997) (115)
- Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes. (2010) (115)
- Sentinel Lymph Node Biopsy in Histologically Ambiguous Melanocytic Tumors With Spitzoid Features (So-Called Atypical Spitzoid Tumors) (2008) (115)
- Frequency and duration of remission after isolated limb perfusion for melanoma. (1997) (115)
- BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage (2013) (114)
- Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database (2010) (113)
- Pathologic examination of sentinel lymph nodes from melanoma patients. (2008) (112)
- Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma (2012) (111)
- Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs (1992) (110)
- Ultrasound Examination of Sentinel Nodes in the Initial Assessment of Patients With Primary Cutaneous Melanoma (2004) (107)
- Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. (1988) (106)
- Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy (2008) (105)
- Pathologic Review of Negative Sentinel Lymph Nodes in Melanoma Patients With Regional Recurrence: A Clinicopathologic Study of 1152 Patients Undergoing Sentinel Lymph Node Biopsy (2003) (105)
- Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? (2001) (103)
- SOX2 contributes to melanoma cell invasion (2012) (102)
- Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. (2014) (102)
- Expression of glucose‐regulated stress protein GRP78 is related to progression of melanoma (2009) (101)
- Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease—Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004 (2007) (101)
- Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines (2007) (99)
- Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma (2014) (95)
- Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial. (2019) (94)
- Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma (2008) (93)
- Desmoplastic neurotropic melanoma (2008) (93)
- Atypical Spitzoid Melanocytic Tumors With Positive Sentinel Lymph Nodes in Children and Teenagers, and Comparison With Histologically Unambiguous and Lethal Melanomas (2009) (93)
- Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma (2005) (91)
- A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. (1983) (91)
- Locally advanced melanoma (2020) (91)
- Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. (2011) (90)
- Isolated limb infusion with melphalan for recurrent limb melanoma : a simple alternative to isolated limb perfusion (1994) (90)
- Long-term Results of Hyperthermic, Isolated Limb Perfusion for Melanoma: A Reflection of Tumor Biology (2007) (90)
- Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. (2002) (88)
- The advantage of using a synoptic pathology report format for cutaneous melanoma (2007) (88)
- A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma (2005) (88)
- Venous Thoracic Outlet Compression and the Paget-Schroetter Syndrome: A Review and Recommendations for Management (2011) (88)
- Keystone Flap Reconstruction of Primary Melanoma Excision Defects of the Leg—The End of the Skin Graft? (2008) (88)
- Surgery for melanoma metastases of the gastrointestinal tract: indications and results. (2009) (87)
- Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma (2012) (86)
- Tumor-infiltrating lymphocytes and their significance in melanoma prognosis. (2014) (86)
- Local and intralesional therapy of in‐transit melanoma metastases (2011) (86)
- A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma (2015) (86)
- Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. (2009) (86)
- Data Set for Pathology Reporting of Cutaneous Invasive Melanoma (2013) (85)
- MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. (2018) (85)
- Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy (2001) (84)
- Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. (2006) (84)
- Follow‐up schedules after treatment for malignant melanoma (2008) (84)
- Lymphatic mapping in management of patients with primary cutaneous melanoma. (2005) (83)
- Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. (1992) (83)
- Intestinal and Multivisceral Transplantation (2002) (82)
- Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases (2017) (79)
- Radiotherapy for lentigo maligna: a literature review and recommendations for treatment (2014) (79)
- Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine (2012) (78)
- PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma (2016) (78)
- Popliteal lymph node metastasis from primary cutaneous melanoma. (2000) (77)
- In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy (2015) (77)
- Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma (2005) (77)
- Lymphedema After Complete Axillary Node Dissection for Melanoma: Assessment Using a New, Objective Definition (2004) (76)
- Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma (2007) (76)
- Genetic and clinico-pathologic analysis of metastatic uveal melanoma (2014) (75)
- Textbook of melanoma (2004) (73)
- Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection in Patients With Cutaneous Melanoma (2004) (73)
- Lactate dehydrogenase 5 expression in melanoma increases with disease progression and is associated with expression of Bcl-XL and Mcl-1, but not Bcl-2 proteins (2010) (73)
- Epigenetic profiling for the molecular classification of metastatic brain tumors (2018) (73)
- Intrapatient Homogeneity of BRAFV600E Expression in Melanoma (2014) (72)
- The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis☆ (2015) (72)
- Pathology of melanocytic lesions: New, controversial, and clinically important issues (2004) (71)
- Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases (1989) (71)
- Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. (1996) (70)
- Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial (2011) (70)
- Proposed Quality Standards for Regional Lymph Node Dissections in Patients With Melanoma (2009) (69)
- Genetic alterations and personalized medicine in melanoma: progress and future prospects. (2014) (69)
- Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases (2015) (67)
- Imaging in cutaneous melanoma (2008) (67)
- Thoracic outlet syndrome caused by chronic retrosternal dislocation of the clavicle. Successful treatment by transaxillary resection of the first rib. (2002) (67)
- Defining Lower Limb Lymphedema After Inguinal or Ilio-Inguinal Dissection in Patients With Melanoma Using Classification and Regression Tree Analysis (2008) (67)
- An Analysis of the Association between Serum Citrulline and Acute Rejection among 26 Recipients of Intestinal Transplant (2004) (67)
- Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients (2007) (66)
- Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity (2020) (66)
- Determination of prognosis in metastatic melanoma through integration of clinico‐pathologic, mutation, mRNA, microRNA, and protein information (2015) (66)
- Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes (2009) (66)
- Serum citrulline and rejection in small bowel transplantation: a preliminary report. (2001) (66)
- Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma. (2016) (66)
- Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors (2018) (64)
- Analysis of Acute Cellular Rejection Episodes in Recipients of Primary Intestinal Transplantation: A Single Center, 11‐Year Experience (2007) (64)
- CYCLOSPORIN CONVERSION VERSUS CONVENTIONAL IMMUNOSUPPRESSION: LONG-TERM FOLLOW-UP AND HISTOLOGICAL EVALUATION (1987) (64)
- Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. (2007) (64)
- Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment (2014) (64)
- PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors (2017) (64)
- Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. (2011) (63)
- Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma (2014) (63)
- Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma (2012) (62)
- Sudden death following high-dose intravenous methylprednisolone. (1983) (62)
- Intestinal transplantation in children: A summary of clinical outcomes and prognostic factors in 108 patients from a single center (2007) (61)
- Targeted alpha therapy for cancer. (2004) (61)
- Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. (1983) (61)
- Sentinel lymph node detection and imaging. (1999) (61)
- Cyclosporin and renal graft histology. (1986) (60)
- Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial. (2019) (59)
- The rationale for sentinel-node biopsy in primary melanoma (2008) (59)
- Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991. (1995) (59)
- Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients (2009) (59)
- Elective lymph node dissection. (1995) (58)
- Histopathologic Excision Margin Affects Local Recurrence Rate: Analysis of 2681 Patients With Melanomas ≤2 mm Thick (2005) (58)
- Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma (2004) (57)
- Improving doctors' letters (2002) (57)
- RAB27A promotes melanoma cell invasion and metastasis via regulation of pro‐invasive exosomes (2019) (57)
- Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma (2009) (57)
- Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. (2010) (57)
- Angiotropism is an Independent Predictor of Local Recurrence and In-transit Metastasis in Primary Cutaneous Melanoma (2008) (56)
- False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy (2009) (56)
- Isolated limb infusion for melanoma: A simple but effective alternative to isolated limb perfusion (2004) (56)
- Maximizing efficacy and minimizing toxicity in isolated limb perfusion for melanoma. (1994) (55)
- Three-dimensional visualisation of lymphatic drainage patterns in patients with cutaneous melanoma. (2007) (55)
- Spitz naevus: diagnostic problems and their management implications. (2004) (55)
- Cost-effectiveness of Adding FDG-PET or CT to the Diagnostic Work-up of Patients With Stage III Melanoma (2012) (55)
- The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. (2001) (55)
- MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis (2015) (54)
- DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations. (2014) (54)
- Intraoperative heparinisation, blood loss and myocardial infarction during aortic aneurysm surgery: a Joint Vascular Research Group study. (1996) (54)
- The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas (2013) (53)
- Surgical treatment of splenic metastases in patients with melanoma. (2003) (53)
- The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients (2009) (53)
- The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma (2009) (53)
- The prognosis of patients with thick primary melanomas: Is regional lymph node status relevant, and does removing positive regional nodes influence outcome? (2002) (53)
- So‐called “malignant blue nevus” (2009) (52)
- Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. (2002) (52)
- Increased expression of apoptotic markers in melanoma (2003) (52)
- Advantages of polytetrafluoroethylene arteriovenous loops in the thigh for hemodialysis access. (1997) (52)
- Absence of distinguishing senescence traits in human melanocytic nevi. (2012) (52)
- Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients (2018) (52)
- Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity (2008) (52)
- Lymph Node Ratio Provides Prognostic Information in Addition to American Joint Committee on Cancer N Stage in Patients With Melanoma, Even If Quality of Surgery Is Standardized (2011) (51)
- The detection and significance of melanoma micrometastases in sentinel nodes. (2008) (51)
- p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. (2008) (51)
- Sentinel node biopsy for melanoma: Where have we been and where are we going? (2004) (50)
- Sentinel node mapping for melanoma: results of trials and current applications. (2007) (50)
- A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: The use of monoclonal antibodies and double immunolabeling (1990) (50)
- Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy? (2004) (50)
- Lymphatic Drainage From Peri-Umbiiical Skin to Internal Mammary Nodes (1995) (50)
- Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram. (2020) (50)
- Multivisceral transplantation for megacystis microcolon intestinal hypoperistalsis syndrome. (1999) (50)
- Factors Predictive of Acute Regional Toxicity After Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma Patients (2009) (50)
- Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors (2006) (50)
- Topical diphencyprone immunotherapy for cutaneous metastatic melanoma (2009) (49)
- Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma (2007) (49)
- Surgeons’ Opinions on Lymphadenectomy in Melanoma Patients with Positive Sentinel Nodes: A Worldwide Web-Based Survey (2012) (48)
- Elemental bio-imaging of melanoma in lymph node biopsies. (2009) (48)
- Melanomas of unknown primary have a mutation profile consistent with cutaneous sun‐exposed melanoma (2013) (48)
- Isolated limb infusion with fotemustine after dacarbazine chemosensitisation for inoperable loco-regional melanoma recurrence. (2004) (47)
- Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors (2013) (47)
- A highly recurrent RPS27 5'UTR mutation in melanoma (2014) (47)
- The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study (2016) (47)
- Isolated Limb Perfusion in the Management of Patients With Recurrent Limb Melanoma: An Important but Limited Role (2001) (47)
- Interobserver Variation in the Histopathologic Reporting of Key Prognostic Parameters, Particularly Clark Level, Affects Pathologic Staging of Primary Cutaneous Melanoma (2009) (47)
- Human Cancer Biology Distinguishing Clinicopathologic Features of Patients with V 600 E and V 600 K BRAF-Mutant Metastatic Melanoma (2012) (47)
- Isolated limb infusion with melphalan and actinomycin D for melanoma: A systematic review (2014) (47)
- Extended experience and modifications in the design and concepts of the keystone design island flap. (2010) (46)
- Reduced p16 and Increased Cyclin D1 and pRb Expression Are Correlated With Progression in Cutaneous Melanocytic Tumors (2009) (46)
- Long‐term clinical and functional outcome following treatment for Paget–Schroetter syndrome (2013) (46)
- Portosystemic shunting in children during the era of endoscopic therapy: improved postoperative growth parameters. (2000) (46)
- Interleukin-10 regulates arterial pressure in early primate pregnancy. (2005) (45)
- Molecular Genomic Profiling of Melanocytic Nevi. (2019) (45)
- Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. (2020) (45)
- Evaluation of Sex-Specific Incidence of Melanoma. (2020) (45)
- Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients (2011) (45)
- Margins of excision and prognostic factors for cutaneous eyelid melanomas. (2013) (44)
- Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population (2011) (44)
- Cutaneous melanomas that defy conventional prognostic indicators. (1996) (44)
- Isolated limb infusion: A review (2009) (44)
- Treatment of extensive cutaneous metastatic melanoma with topical diphencyprone. (2007) (43)
- Frequency of nonsentinel lymph node metastasis in melanoma (2002) (43)
- Three‐dimensional visualization of skin lymphatic drainage patterns of the head and neck (2009) (43)
- Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion (2011) (43)
- Desmoplastic Melanoma: A Heterogeneous Entity in Which Subclassification as “Pure” or “Mixed” May Have Important Prognostic Significance (2005) (43)
- Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution (2014) (43)
- Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries (2013) (43)
- Clinical examination of varicose veins--a validation study. (2001) (42)
- Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm) (1998) (42)
- The justification for surgical treatment of metastatic melanoma of the gastrointestinal tract. (1990) (42)
- Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors (2015) (42)
- SKIN CANCER IN RENAL TRANSPLANT PATIENTS TREATED WITH CYCLOSPORIN (1985) (42)
- Primary mucosal and glans penis melanomas: the Sydney Melanoma Unit experience. (1999) (42)
- Role of lymphoscintigraphy for selective sentinel lymphadenectomy. (2005) (42)
- Tacrolimus and diarrhea: Pathogenesis of altered metabolism (2001) (42)
- Quality of histopathological reporting on melanoma and influence of use of a synoptic template (2010) (42)
- Sentinel lymph nodes in malignant melanoma: Extended histopathologic evaluation improves diagnostic precision (2004) (42)
- False Negative Sentinel Lymph Node Biopsies in Melanoma May Result From Deficiencies in Nuclear Medicine, Surgery, or Pathology (2008) (42)
- Plasma cells in primary melanoma. Prognostic significance and possible role of IgA (2016) (41)
- Patients' perspectives of long-term follow-up for localised cutaneous melanoma. (2013) (41)
- Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01). (2009) (41)
- Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. (2005) (41)
- Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis (2009) (41)
- Sex differences in oncogenic mutational processes (2019) (41)
- The role of intestinal transplantation in the management of babies with extensive gut resections. (2003) (40)
- Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression (2013) (40)
- Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients (1997) (39)
- The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma (2007) (39)
- Latex allergy: an emerging clinical and occupational health problem (1997) (39)
- Sentinel Node Positive Melanoma Patients: Prediction and Prognostic Significance of Nonsentinel Node Metastases and Development of a Survival Tree Model (2010) (39)
- Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasis (2012) (38)
- Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients (2019) (38)
- Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients (2012) (38)
- Sentinel node biopsy (1997) (38)
- Superior survival of young women with malignant melanoma. (1999) (38)
- Definitive radiotherapy or chemoradiotherapy in the treatment of Merkel cell carcinoma. (2012) (38)
- Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma (2012) (37)
- Long-term Survival and Occasional Regression of Distant Melanoma Metastases after Adrenal Metastasectomy (2008) (37)
- BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma (2013) (37)
- Epitrochlear lymph nodes as a site of melanoma metastasis (1998) (37)
- The place of duplex scanning for varicose veins and common venous problems. (1996) (37)
- Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer. (2004) (37)
- Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients (2019) (37)
- Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis. (2017) (37)
- Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D) (2014) (37)
- The Complex Relationships Between Sentinel Node Positivity, Patient Age, and Primary Tumor Desmoplasia: Analysis of 2303 Melanoma Patients Treated at a Single Center (2008) (36)
- Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1–2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center (2016) (36)
- Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies (2001) (36)
- Current status of small bowel transplantation in children: update 2003. (2003) (36)
- Effect of aprotinin on neutrophil function after major vascular surgery (1992) (36)
- Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01). (2009) (36)
- 1220PDPhase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma (2017) (36)
- Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma. (2007) (36)
- The history of sentinel lymph node biopsy. (2015) (36)
- Vascular complications following orthotopic liver transplantation. (1990) (35)
- Promoter hypermethylation of the O(6)-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma. (2006) (35)
- Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients. (2019) (35)
- The Challenge of Defining Guidelines for Sentinel Lymph Node Biopsy in Patients with Thin Primary Cutaneous Melanomas (2012) (35)
- Intestinal transplantation for short gut syndrome attributable to necrotizing enterocolitis. (2000) (34)
- Nuclear medicine aspects of melanoma and breast lymphatic mapping. (2004) (34)
- Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. (2003) (34)
- Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease (2014) (34)
- EDITORIAL — What is a «sentinel» lymph node? (2000) (34)
- TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells (2014) (33)
- Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas (2017) (33)
- Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma (2012) (33)
- Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients (1998) (33)
- Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance. (2021) (33)
- BAP1 expression in cutaneous melanoma: a pilot study. (2013) (33)
- Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas (2014) (33)
- Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes (2013) (32)
- Primary Melanoma of the Lung (2007) (32)
- High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. (1999) (32)
- Updated evidence‐based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma (2018) (32)
- Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility (2018) (32)
- Pathology Review Significantly Affects Diagnosis and Treatment of Melanoma Patients: An Analysis of 5011 Patients Treated at a Melanoma Treatment Center (2014) (32)
- Aortic occlusion and vascular isolation allowing avascular hepatic resection. (1990) (32)
- Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma. (2004) (32)
- Sentinel Node Status Prediction by Four Statistical Models: Results From a Large Bi-Institutional Series (n = 1132) (2009) (32)
- Sentinel nodes. Interval nodes, lymphatic lakes, and accurate sentinel node identification. (2000) (31)
- Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis (2019) (31)
- Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanoma (2015) (31)
- Aprotinin in peripheral vascular surgery (1990) (31)
- Patterns of Recurrence and Survival After Lymphadenectomy in Melanoma Patients: Clarifying the Effects of Timing of Surgery and Lymph Node Tumor Burden (2013) (31)
- Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. (2006) (31)
- Subungual Melanoma of the Hand (2018) (31)
- Trends in serum citrulline and acute rejection among recipients of small bowel transplants. (2004) (31)
- Detection of metastatic disease in patients with uveal melanoma using positron emission tomography. (2006) (31)
- The symptoms of varicose veins: difficult to determine and difficult to study. (2007) (31)
- Melanoma of the Vulva and Vagina: Principles of Staging and Their Relevance to Management Based on a Clinicopathologic Analysis of 85 Cases (2015) (30)
- Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. (2009) (30)
- Isolated melanoma in the lung where there is no known primary site: metastatic disease or primary lung tumour? (2005) (30)
- Sentinel Lymph Nodes Containing Very Small (<0.1 mm) Deposits of Metastatic Melanoma Cannot Be Safely Regarded as Tumor-Negative (2012) (30)
- Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas (2019) (30)
- Safety and Efficacy of Isolated Limb Infusion With Cytotoxic Drugs in Elderly Patients With Advanced Locoregional Melanoma (2009) (30)
- First rib resection for vascular complications of thoracic outlet syndrome (1990) (30)
- Cadaveric liver procurement using aortic perfusion only. (1998) (30)
- Detection of second primary cutaneous melanomas. (2008) (30)
- Lymph-node metastases in patients with melanoma: what is the optimum management? (2001) (29)
- Increasing Tumor Thickness is Associated with Recurrence and Poorer Survival in Patients with Merkel Cell Carcinoma (2012) (29)
- The value of monitoring serum creatine phosphokinase following hyperthermic isolated limb perfusion for melanoma (1993) (29)
- Malignant melanoma in childhood: A clinicopathologic study of 13 cases and comparison with spitz nevi (1992) (29)
- Follow‐up of early stage melanoma: Specialist clinician perspectives on the functions of follow‐up and implications for extending follow‐up intervals (2013) (28)
- Rectal diclofenac compared with pethidine injection in acute renal colic. (1989) (28)
- Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma (2011) (28)
- Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia (2017) (28)
- Pharmacokinetics and pharmacodynamics of melphalan in isolated limb infusion for recurrent localized limb malignancy (2001) (28)
- Saturable dose–response relationships for melphalan in melanoma treatment by isolated limb infusion in the nude rat (2001) (28)
- Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution (2011) (28)
- A percutaneous aortic stop-flow infusion technique for regional cytotoxic therapy of the abdomen and pelvis (1994) (28)
- The important role of radiation treatment in the management of Merkel cell carcinoma (2013) (28)
- Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. (2006) (27)
- Hand‐held Doppler as a screening test in primary varicose veins (1997) (27)
- Variability of cutaneous lymphatic flow rates in melanoma patients (1998) (27)
- Functional anatomy of the lymphatics draining the skin: a detailed statistical analysis (2010) (27)
- Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center (2017) (27)
- The molecular profile of metastatic melanoma in Australia. (2016) (27)
- Factors influencing the early outcome of major lower limb amputation for vascular disease. (2001) (27)
- Malignant melanoma of the toenail apparatus. (1995) (27)
- Failure to remove true sentinel nodes can cause failure of the sentinel node biopsy technique: Evidence from antimony concentrations in false-negative sentinel nodes from melanoma patients (2004) (27)
- Graft survival in pediatric liver transplantation. (2001) (27)
- The utility of ultrasound in patients with melanoma (2007) (27)
- The living, related kidney donor: a follow‐up study (1988) (27)
- Total Sentinel Lymph Node Tumor Size Predicts Nonsentinel Node Metastasis and Survival in Patients with Melanoma (2010) (27)
- In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. (2005) (27)
- Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study (2017) (27)
- Australian Multicenter Study of Isolated Limb Infusion for Melanoma (2016) (26)
- Prospective randomised evaluation of a new cell saving device in elective aortic reconstruction. (1990) (26)
- Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value (2020) (26)
- GOUT AND HYPERURICAEMIA IN PATIENTS ON CYCLOSPORIN AND DIURETICS (1985) (26)
- Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis. (2006) (26)
- Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma (2011) (26)
- Intestinal transplantation for short bowel syndrome secondary to gastroschisis. (2006) (26)
- Acute and subacute fulminant hepatic failure: the role of liver transplantation (1991) (26)
- Diagnostic Accuracy of Fine Needle Biopsy for Metastatic Melanoma and Its Implications for Patient Management (2007) (26)
- False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma (2019) (26)
- Tumour gene expression signature in primary melanoma predicts long-term outcomes (2020) (26)
- Quality assurance in melanoma surgery: The evolving experience at a large tertiary referral centre. (2015) (25)
- Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma (2004) (25)
- The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma. (2006) (25)
- Intramedullary spinal cord metastasis from carcinoma of the lung: detection by positron emission tomography. (1997) (25)
- Intestinal transplantation at the University of Miami. (2002) (25)
- Most patients with varicose veins have fears or concerns about the future, in addition to their presenting symptoms. (2006) (25)
- Donor portal vein arterialization during liver transplantation. (1989) (25)
- Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2) (2021) (25)
- Anatomic position determines oncogenic specificity in melanoma (2020) (25)
- Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice (2018) (25)
- Incidence of new primary melanomas after diagnosis of stage III and IV melanoma. (2014) (24)
- Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. (1997) (24)
- Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers. (2019) (24)
- Isolated limb perfusion and isolated limb infusion for malignant lesions of the extremities. (2011) (24)
- Late axillo-brachial arterial aneurysm following ligated Brescia-Cimino haemodialysis fistula. (2001) (24)
- The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma (2017) (24)
- Isolated Limb Infusion as Palliative Treatment for Advanced Limb Disease in Patients with AJCC Stage IV Melanoma (2009) (24)
- Cutaneous melanoma in childhood: Incidence and prognosis (1997) (24)
- Varicose vein surgery using a pneumatic tourniquet: reduced blood loss and improved cosmesis. (1990) (23)
- Use of a pneumatic tourniquet improves outcome following trans-tibial amputation. (2006) (23)
- Pigmented epithelioid melanocytoma. (2004) (23)
- Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials (2019) (23)
- Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients. (2013) (23)
- Attitudes to xenotransplantation: scientific enthusiasm, assumptions and evidence. (1998) (23)
- Gentamicin beads in vascular surgery: long-term results of implantation. (1999) (23)
- Teaching points on lymphatic mapping for melanoma from the Sydney Melanoma Unit. (2004) (23)
- TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone. (2010) (23)
- Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy. (1997) (23)
- Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens (2004) (23)
- Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma. (2017) (23)
- Aversion to xenotransplantation (1995) (23)
- Contralateral groin node metastasis from lower limb melanoma. (1997) (23)
- BRAF mutation by age-decade and body mass index in metastatic melanoma. (2011) (22)
- Fine-needle biopsy of metastatic melanoma: clinical use and new applications. (2010) (22)
- Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens (2003) (22)
- Determinants of acute regional toxicity following isolated limb perfusion for melanoma (1996) (22)
- BENEFITS OF SENTINEL NODE BIOPSY FOR MELANOMA: A REVIEW BASED ON INTERIM RESULTS OF THE FIRST MULTICENTER SELECTIVE LYMPHADENECTOMY TRIAL (2006) (22)
- Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases. (2019) (22)
- Sentinel Node Metastasis From Thin Melanomas With Vertical Growth Phase (2000) (22)
- Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
- Embolisation of host kidneys for the control of hypertension after renal transplantation: radiological aspects. (1984) (21)
- The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma (2006) (21)
- The first five years' clinical experience of the Australian National Liver Transplantation Unit. (1992) (21)
- Exclusive lymphatic drainage from a melanoma on the back to intraabdominal lymph nodes. (1998) (21)
- Is Sentinel Lymph Node Biopsy Appropriate in Patients With Thin Melanomas: Too Early To Tell? (2006) (21)
- Variation in cutaneous lymphatic flow rates (1997) (21)
- Evidence-based clinical practice guidelines on the use of sentinel lymph node biopsy in melanoma. (2013) (21)
- Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence (2020) (21)
- Renal function after pediatric intestinal transplant. (2006) (21)
- Isolated limb infusion: Technical aspects (2014) (21)
- Routine use of auxiliary partial orthotopic liver transplantation for children with fulminant hepatic failure: Preliminary report. (2006) (21)
- Clinical and Pathologic Factors Associated with Distant Metastasis and Survival in Patients with Thin Primary Cutaneous Melanoma (2012) (21)
- The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma (2006) (21)
- Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study. (2011) (21)
- Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians’ perspectives and models of care (2012) (21)
- The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma (2006) (21)
- Reproducibility of AJCC Staging Parameters in Primary Cutaneous Melanoma: An Analysis of 4,924 Cases (2013) (21)
- Direct lymphatic drainage from the skin of the forearm to a supraclavicular node. (1996) (21)
- Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features (2017) (20)
- Survival in patients with desmoplastic melanoma. (2006) (20)
- Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas (2014) (20)
- Local and regional therapies for melanoma: Many arrows in the quiver (2014) (20)
- Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma (2020) (20)
- A risk prediction model for the development of subsequent primary melanoma in a population‐based cohort (2020) (20)
- Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna (2019) (20)
- Temporary wound closure with expanded polytetrafluoroethylene in pediatric liver transplantation. (1992) (20)
- Lymph node ratio in melanoma (2009) (20)
- Histological expression of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) in human primary melanoma (2004) (20)
- Growth after intestinal transplant in children. (2006) (20)
- An explosive outbreak of Q fever. (1953) (20)
- Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma. (2017) (19)
- Pharmacokinetics of melphalan during isolated limb infusion for melanoma (1996) (19)
- Reconstruction after wide excision of primary cutaneous melanomas: part I-the head and neck. (2009) (19)
- Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study (2017) (19)
- What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire (2013) (19)
- Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma. (2008) (19)
- Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients? (2008) (19)
- Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. (2020) (19)
- Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell. (2006) (19)
- Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: Incidence varies with primary tumor site (1998) (19)
- Sex Differences in Melanoma Survival are Not Related to Mitotic Rate of the Primary Tumor (2015) (19)
- Melanoma Metastases in Regional Lymph Nodes Are Accurately Detected by Proton Magnetic Resonance Spectroscopy of Fine-Needle Aspirate Biopsy Samples (2005) (19)
- Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy (2009) (19)
- Liver Graft Revascularization by Donor Portal Vein Arterialization Following “No Touch” Donor Hepatectomy (1988) (18)
- Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. (2008) (18)
- Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary. (2011) (18)
- Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors (2013) (18)
- The history and future of melanoma staging (2004) (18)
- CONTROL OF HYPERTENSION AFTER RENAL TRANSPLANTATION BY EMBOLISATION OF HOST KIDNEYS (1984) (18)
- Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens (2018) (18)
- Ultrasound assessment of lymph nodes in the management of early‐stage melanoma (2011) (18)
- Limitations of percutaneous transluminal angioplasty in the treatment of femoro-distal graft stenoses. (1989) (18)
- Is Melphalan Dose Adjustment According to Ideal Body Weight Useful in Isolated Limb Infusion for Melanoma? (2012) (18)
- Detection of unsuspected spinal cord compression in melanoma patients by 18F-fluorodeoxyglucose-positron emission tomography. (2005) (18)
- Survival superiority of females with melanoma. (1994) (18)
- Selective sentinel lymphadenectomy: progress to date and prospects for the future. (2005) (18)
- Current status of isolated limb infusion with mild hyperthermia for melanoma (2008) (18)
- Hypertrichosis and Multiple Cutaneous Squamous Cell Carcinomas in Association with Cyclosporin a Therapy 1 (1983) (18)
- Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia (2018) (17)
- Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma (2020) (17)
- Major Amputation for Irresectable Extremity Melanoma After Failure of Isolated Limb Infusion (2009) (17)
- Lymphoma occurring in patients with cutaneous melanoma (2010) (17)
- Amputation for Acute Ischaemia is Associated with Increased Comorbidity and Higher Amputation Level (2003) (17)
- Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma. (2020) (17)
- Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients (2014) (17)
- The Management of Cervical Lymph Nodes in Patients with Cutaneous Melanoma (2012) (17)
- Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice (2016) (17)
- Mazabraud's syndrome: intramuscular myxoma associated with fibrous dysplasia of bone. (1990) (17)
- Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma (2011) (17)
- Quality of life patient-reported outcomes for locally advanced cutaneous melanoma (2017) (16)
- The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients (2011) (16)
- Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. (2003) (16)
- Failure to detect drainage to the popliteal and epitrochlear lymph nodes on cutaneous lymphoscintigraphy in melanoma patients. (1998) (16)
- Multicenter Selective Lymphadenectomy Trial‐I confirms the central role of sentinel node biopsy in contemporary melanoma management (2015) (16)
- Subungual Melanoma of the Hand. (1996) (16)
- A novel hypoxia-associated subset of FN1highMITFlow melanoma cells: identification, characterization, and prognostic value (2014) (16)
- Reconstruction after wide excision of primary cutaneous melanomas: part II--the extremities. (2009) (16)
- Treatment of Refractory Chromomycosis by Isolated Limb Infusion with Melphalan and Actinomycin D (2006) (16)
- Inter‐ and intrapatient heterogeneity of indoleamine 2,3‐dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment (2019) (15)
- Non-Subungual Melanomas of the Hand (1992) (15)
- First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality (2015) (15)
- Imaging Sentinel Lymph Nodes (2015) (15)
- Antimony concentrations in nodal tissue can confirm sentinel node identity (2004) (15)
- Adjuvant radiotherapy after lymphadenectomy in melanoma patients: Final results of an intergroup randomized trial (ANZMTG 0.1.02/TROG 02.01). (2013) (15)
- Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases (2015) (15)
- Return to work, driving and other activities after varicose vein surgery is very variable and is influenced little by advice from specialists. (2009) (15)
- The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population‐based data on diagnosis and management (2018) (15)
- Common bile duct obstruction due to intraluminal metastatic melanoma. (1993) (15)
- Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. (2021) (15)
- Melanoma of the lip. (1996) (15)
- Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module (2015) (15)
- [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. (2008) (15)
- The Unpredictability of Lymphatic Drainage from the Ear in Melanoma Patients, and Its Implications for Management (2013) (14)
- Digital papillary adenocarcinoma: a tumour that should be considered in the differential diagnosis of neoplasms involving the digits (2013) (14)
- Hyperthermic isolated limb perfusion in the treatment of melanoma : technical aspects (1994) (14)
- The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients. (2008) (14)
- Fine-needle biopsy as a diagnostic technique for metastatic melanoma. (2008) (14)
- Non-operative treatment of advanced limb ischaemia: the decision for palliative care. (2000) (14)
- LNK suppresses interferon signaling in melanoma (2019) (14)
- Initial report of the Australian National Pilot Liver Transplantation Programme. (1987) (14)
- Radiofrequency ablation in metastatic melanoma (2014) (14)
- The problem of cytomegalovirus infection in renal allograft recipients. (1984) (14)
- Futility of imaging to stage melanoma patients with a positive sentinel lymph node (2017) (14)
- Role of T-cell-subset monitoring in renal-allograft recipients. (1982) (14)
- High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial (2005) (14)
- Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC) (2022) (13)
- EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. (2015) (13)
- Melanoma Metastases in Triangular Intermuscular Space Lymph Nodes (1999) (13)
- Association Between Melanoma Detected During Routine Skin Checks and Mortality. (2021) (13)
- Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia. (2020) (13)
- Surgical resection of pulmonary metastatic melanoma: A review of 83 thoracotomies (1996) (13)
- Melanoma and other skin tumors (2012) (13)
- Melanoma patient imaging in the era of effective systemic therapies. (2017) (13)
- The Sydney Melanoma Unit--a multidisciplinary melanoma treatment center. (2003) (13)
- Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management (2016) (13)
- Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population‐based study in New South Wales, Australia (2017) (13)
- Right chylothorax following left radical neck dissection. (1993) (13)
- Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma (2019) (13)
- The Role of Sentinel Lymph Node Biopsy in Patients with Merkel Cell Carcinoma: Uncertainty Prevails (2014) (13)
- Melanoma of the nose (1997) (13)
- Contamination and decontamination of Doppler probes. (2006) (13)
- Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial. (2021) (13)
- BAP1-inactivated spitzoid naevi. (2015) (12)
- Melanotic schwannoma mimicking metastatic pigmented melanoma: a pitfall in cytological diagnosis. (2010) (12)
- When is a sentinel node biopsy indicated for patients with primary melanoma? An update of the ‘Australian guidelines for the management of cutaneous melanoma’ (2017) (12)
- The Identification of Potential Cadaveric Organ Donors (1995) (12)
- Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion From MLST-II: Multi-Institutional Propensity Score Matched Analysis. (2020) (12)
- Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus. (2007) (12)
- Anaesthesia and analgesia for major lower limb amputation. (2000) (12)
- Can Cadaveric Organ Donation Rates be Improved? (1995) (12)
- Pediatric liver transplant with Campath 1H induction--Preliminary report. (2006) (12)
- The Optimum Excision Margin and Regional Node Management for Primary Cutaneous T3 Melanomas (2–4 mm in Thickness): A Retrospective Study of 1587 Patients Treated at a Single Center (2014) (12)
- Surgical oncology and the role of regional chemotherapy. (1992) (12)
- Biospecimen banking: The pathway to personalized medicine for patients with cancer (2013) (12)
- CASE REPORT Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D (2001) (12)
- International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin (2014) (12)
- Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy (1983) (12)
- Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage iiib/c BRAF-V600 mutation positive melanoma. (2016) (12)
- Free flap reconstruction for melanoma of the head and neck: indications and outcomes. (2010) (12)
- Australian National Pilot Liver Transplantation Program: the first year's report. (1988) (12)
- The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma (2010) (12)
- The Miami experience with almost 100 multivisceral transplants. (2006) (11)
- Sentinel-node biopsy in melanoma. (2014) (11)
- What is a 'sentinel' lymph node? (2000) (11)
- Immunoperoxidase staining of fine-needle aspiration biopsies and needle core biopsies from renal allografts. (1983) (11)
- The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma (2019) (11)
- Peritoneal melanosis associated with metastatic melanoma involving the omentum. (2012) (11)
- Managing in-transit melanoma metastases in the new era of effective systemic therapies for melanoma (2019) (11)
- The value of sentinel node biopsy in patients with primary cutaneous melanoma. (2008) (11)
- The association between active tumor volume, total lesion glycolysis and levels of S-100B and LDH in stage IV melanoma patients. (2020) (11)
- Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible (2014) (11)
- Intestinal transplantation: advances in immunosuppression and surgical techniques. (2003) (11)
- Can We Better Identify Thin Cutaneous Melanomas That are Likely to Metastasize and Cause Death? (2012) (11)
- Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients (2005) (11)
- Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts (2018) (11)
- Clinical pharmacokinetics of melphalan in isolated limb perfusion : compartmental modelling and moment analysis (1995) (11)
- Germline BAP1 mutations also predispose to cutaneous squamous cell carcinoma. (2017) (11)
- Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy (2016) (11)
- Double isolated limb infusion with cytotoxic agents for recurrent and metastatic limb melanoma (2001) (11)
- Mapping Melanoma Lymphoscintigraphy Data onto a 3D Anatomically Based Model (2007) (11)
- Necrotizing fasciitis following liver and small intestine transplantation (2002) (11)
- Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas (2020) (10)
- Expanded use of multivisceral transplantation for small children with concurrent liver and intestinal failure. (2006) (10)
- Cytological features of melanoma in exfoliative fluid specimens (2009) (10)
- How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center? (2015) (10)
- An Integrated Tree-Based Classification Approach to Prognostic Grouping with Application to Localized Melanoma Patients (2007) (10)
- Autotransfusion (1991) (10)
- Staging and prognostic factors for stage IV melanoma: Initial results of an American Joint Committee on Cancer (AJCC) international evidence-based assessment of 4,895 melanoma patients (2008) (10)
- The FACT-Melanoma Quality-of-Life Instrument: comparison of a five-point and four-point response scale using the Rasch measurement model (2013) (10)
- Chemoablation of metastatic melanoma with rose bengal (PV-10). (2010) (10)
- MONOCLONAL ANTIBODIES AND FINE NEEDLE ASPIRATION CYTOLOGY IN DETECTING RENAL ALLOGRAFT REJECTION (1982) (10)
- Lymphatic mapping and sentinel node biopsy: the data unclouded by speculation. (2008) (10)
- 3305 PD1 inhibition-induced changes in melanoma and its associated immune infiltrate (2015) (10)
- Treatment of large, persistent lymphocoeles using an argon beam coagulator and talc. (1998) (10)
- Delayed rupture of the spleen 5 1/2 years after conservative management of traumatic splenic injury. (1996) (10)
- Effects of total hepatectomy: studies in a porcine model. (1994) (9)
- Direct lymphatic drainage from a melanoma on the back to paravertebral lymph nodes in the thorax. (1999) (9)
- Regarding sentinel lymph node localization in early breast cancer. (1999) (9)
- Unilateral piriformis syndrome in a patient with previous melanoma. (1993) (9)
- A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences * (2021) (9)
- The management of pancreatic carcinoma: a review of 173 cases. (1983) (9)
- Publication and Interpretation of Clinical Trial Results: The Need for Caution (2012) (9)
- The role of nuclear medicine in liver transplantation. (1988) (9)
- Routine use of the piggyback technique in pediatric orthotopic liver transplantation. (1996) (9)
- Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor. (2020) (9)
- Naevoid basal cell carcinoma (Gorlin's) syndrome. (1993) (9)
- Poland's anomaly: a diagnostic pitfall in upper limb trauma. (2000) (9)
- Phaeochromocytoma and abdominal aneurysm: confirmation of diagnosis after aortic surgery using mIBG imaging. (1989) (9)
- Normal Growth and Essential Fatty Acid Status in Children With Intestinal Failure on Lipid Limitation (2016) (9)
- Mitotic rate in melanoma should be recorded as the number of mitoses per mm² (not per high power field): surgeons tell your pathologists! (2013) (9)
- Lymphatic drainage patterns from primary cutaneous tumours of the forehead: refining the recommendations for selective neck dissection. (2014) (9)
- Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients (2019) (9)
- Isolated Limb Infusion for Melanoma (2018) (9)
- Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases (2020) (9)
- Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark. (2005) (9)
- Significant impact of HLA class I allele expression on outcome in melanoma patients treated with an allogeneic melanoma cell lysate vaccine. Final analysis of SWOG-9035 (2004) (9)
- Guidelines for imaging in cutaneous melanoma (2008) (9)
- Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients. (2010) (9)
- Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience (2018) (9)
- The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma (2015) (9)
- Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity (2018) (9)
- Internal mammary node metastasis from primary cutaneous melanoma on the anterior chest (2005) (9)
- Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system (2020) (9)
- Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/− Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets (2021) (8)
- Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02. (2014) (8)
- Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging (2017) (8)
- Fulminant hepatic failure and liver transplantation. (1992) (8)
- Primary care support for tackling obesity (2006) (8)
- Topical Diphencyprone Immunotherapy for a Large Primary Melanoma on an Elderly Leg (2011) (8)
- Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma (2012) (8)
- Evaluation of Incomplete Sentinel Node Biopsy Procedures and Sentinel Node Positivity Rates as Surgical Quality-Assurance Parameters in Melanoma Patients (2012) (8)
- Current management of patients with melanoma who are found to be sentinel node‐positive (2019) (8)
- Histological regression in melanoma: impact on sentinel lymph node status and survival (2021) (8)
- Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma (2021) (8)
- Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: A pilot case series (2014) (8)
- Inclusion of spleen in pediatric multivisceral transplantation. (2006) (8)
- Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelines (2021) (8)
- Ocular melanoma in childhood. (1993) (8)
- Vascular surgical training in the UK and Ireland. (1992) (8)
- Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial. (2022) (8)
- International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients (2020) (8)
- Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications (2017) (8)
- Giant infiltrating lipoma of the thigh causing sciatica. (1997) (8)
- SURGICAL PROCEDURES FOR MELANOMA IN PUBLIC AND PRIVATE NEW SOUTH WALES HOSPITALS, 2001–2002 (2006) (8)
- Metastatic occlusion of a lymphatic collecting vessel in a patient with cutaneous melanoma and clinically normal lymph nodes. (2007) (8)
- Portal hypertension and chronic pancreatitis complicating an inflammatory aortic aneurysm. (1989) (8)
- Melanoma - a management guide for GPs. (2012) (8)
- End‐stage renal failure in children: 16 years' experience at one Australian centre (1990) (7)
- Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia (2020) (7)
- Pharmacokinetics of regional therapy: isolated limb infusion and other low flow techniques for extremity melanoma. (2008) (7)
- Efficacy of single-dose ondansetron in the prevention of post-operative nausea and vomiting following isolated limb perfusion with cytotoxic agents (1993) (7)
- Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis (2019) (7)
- Stenting for vein graft stenosis. (1993) (7)
- Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial (2021) (7)
- Response to Comment on "Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does Not Provide Reliable Staging: Results From a Large Multicenter Trial" by Stahlie et al. (2019) (7)
- Treatment of primary Merkel cell carcinoma: Radiotherapy can be an effective, less morbid alternative to surgery. (2020) (7)
- Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging (2019) (7)
- Analysis of rejection episodes in over 100 pediatric intestinal transplant recipients. (2006) (7)
- Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? (2022) (7)
- The value of pre-operative lymphoscintigraphy in breast cancer treatment. (1998) (7)
- Current indications for intestinal transplantation (2000) (7)
- Patient surveillance after cancer treatment (2013) (7)
- Clinico-pathologic correlates of BRAF mutation status in 207 consecutive patients with metastatic melanoma. (2010) (7)
- Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared? (2018) (7)
- Multiple spontaneous ruptures of tendons in renal transplant recipient. (1984) (7)
- Polypoid melanoma is not rare (1996) (7)
- Controversies and evolving concepts in the diagnosis, classification and management of lentigo maligna (2013) (7)
- 1256TiPA Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D+T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial) (2017) (7)
- Diagnostic value of 8.5 T magnetic resonance spectroscopy of benign and malignant skin lesion biopsies (2010) (7)
- Optimum excision margins for melanoma (2011) (7)
- Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials (2017) (7)
- Location of melanoma metastases in sentinel lymph nodes: what are the implications for histologic processing of sentinel lymph nodes in routine practice? (2010) (7)
- Conditional survival estimates for cancer patients (2017) (6)
- Desmoplastic and desmoplastic neurotropic melanoma: 119 (1997) (6)
- Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities (2018) (6)
- Anomalous Lymphatic Drainage Patterns in Patients with Cutaneous Melanoma (2001) (6)
- The carcinoid tumour. (1979) (6)
- Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma (2015) (6)
- Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy (2021) (6)
- Melanoma management in 2007. (2007) (6)
- Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma (2021) (6)
- Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients (2014) (6)
- Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi). (2011) (6)
- Isolated limb perfusion (ILP) for melanoma — maximising efficacy and minimising toxicity: 106 (1993) (6)
- Safety and logistical use of filgrastim (FG) mobilised granulocytes (FMG) in early management of severe neutropenic sepsis (SNS) in acute leukemia (AL) autograft (1996) (6)
- The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study. (2002) (6)
- Multiplex melanoma families are enriched for polygenic risk (2020) (6)
- Improving diagnostic accuracy for suspicious melanocytic skin lesions: New Australian melanoma clinical practice guidelines stress the importance of clinician/pathologist communication. (2019) (6)
- Sentinel lymph node biopsy in pediatric and adolescent patients: a proven technique. (2014) (6)
- Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy (2019) (6)
- Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis (2018) (6)
- T10B9 MONOCLONAL ANTIBODY: SHORT ACTING NON-STIMULATING MONOCLONAL ANTIBODY THT SPARES GAMMA DELTA T-CELLS AND TREATS AND PREVENTS CELLULAR REJECTION.: 1954 (2008) (6)
- IS PREGRAFT BLOOD TRANSFUSION BENEFICIAL IN CYCLOSPORIN-TREATED RENAL TRANSPLANT RECIPIENTS? (1984) (6)
- Surgical management of the neck in patients with metastatic melanoma in parotid lymph nodes (2019) (6)
- Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis. (2021) (6)
- Identification of new prognostic biomarkers for Stage III metastatic melanoma patients (2013) (6)
- Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease (2022) (6)
- Isolated limb perfusion for melanoma: results and complications (2003) (6)
- Immuno-Chemoablation of Metastatic Melanoma with Intralesional Rose Bengal (2012) (6)
- Synchronous and metachronous malignancies in patients with melanoma: a clinicopathologic study highlighting the role of fine-needle biopsy cytology and potential diagnostic pitfalls (2010) (6)
- GPs’ involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study (2020) (6)
- Intestinal autotransplantation for the treatment of pathologic lesions at the root of the mesentery. (2002) (6)
- Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system. (2019) (6)
- Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker (2020) (6)
- Lymphatic mapping and sentinel node biopsy for melanoma (2001) (6)
- Sentinel Lymph Node Biopsy: Evolution of the Technique Since the Original Description by Morton et al. in 1992. (2016) (6)
- Improved survival after liver transplantation for primary biliary cirrhosis. (1989) (6)
- Predicting sentinel node positivity in patients with melanoma: external validation of a risk‐prediction calculator (the Melanoma Institute Australia nomogram) using a large European population‐based patient cohort * (2021) (5)
- Value of prophylactic isolated limb perfusion (ILP) for stage I high risk malignant melanoma: a randomised phase III trial (1997) (5)
- Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity (2010) (5)
- External validation of a prognostic model to predict survival of patients with sentinel node‐negative melanoma (2019) (5)
- Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma. (2014) (5)
- The role of sentinel lymph node biopsy as a staging procedure in patients with melanoma – A critical appraisal (2018) (5)
- Phase 3 International Trial of Adjuvant Whole Brain Radiotherapy (WBRT) or Observation (OBS) Following Local Treatment of 1-3 Melanoma Brain Metastases (MBMs) (2019) (5)
- Current Challenges in Access to Melanoma Care: A Multidisciplinary Perspective. (2021) (5)
- Single-Dose Gentamicin Clearance Is a Predictor of Creatinine Clearance in Spinal Man (2009) (5)
- Providing an acute vascular service: two years experience in a district general hospital. (1996) (5)
- The influence of HLA-A,B and -DR matching on leucocyte infiltration in renal allografts. (2008) (5)
- Ultrasound Examination of the Lymphatic Drainage Area and Regional Lymph Nodes in Melanoma Patients with In-Transit Metastases (2020) (5)
- Atypical fibroxanthoma: differential diagnosis from other sarcomatoid skin lesions (2010) (5)
- Determinants of successful liver transplantation. (1990) (5)
- Diagnosis and management of cutaneous melanoma. (2020) (5)
- Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study. (2020) (5)
- Is there a Role for Isolated Limb Perfusion With Tumor Necrosis Factor in Patients With Melanoma? (2004) (5)
- Direct lymphatic drainage from the skin of the elbow to an interpectoral node (1996) (5)
- Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods study (2020) (5)
- Occlusion of the Profunda Femoris Artery in Competitive Cyclists (2010) (5)
- Gentamicin Beads in Vascular Surgery: Long-Term Results of Implantation (1999) (5)
- Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy (2022) (5)
- Determining optimal sequencing of anti-PD-1 and BRAF-targeted therapy: A phase II randomised study of neoadjuvant pembrolizumab with/without dabrafenib and trametinib (D+T) in BRAF V600 mutant resectable stage IIIb/c/d melanoma (NeoTrio trial). (2018) (5)
- Abstract 5671: Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project (2020) (5)
- Intestinal and multivisceral transplantation. (2004) (5)
- Should patients with melanoma brain metastases receive adjuvant whole-brain radiotherapy? (2015) (5)
- Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients (2007) (5)
- The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: a retrospective cohort study. (2020) (5)
- Local Melanoma Recurrence, Satellitosis, and In-transit Metastasis: Incidence, Outcomes, and Selection of Treatment Options (2019) (5)
- A Novel Immunogen to Modulate Cytokine Production and Promote Immune System Reconstitution in HIV–AIDS (2012) (5)
- International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers (2022) (4)
- Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan (2019) (4)
- Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study. (2019) (4)
- The sentinel lymph node biopsy procedure: identification with blue dye and a gamma probe (2003) (4)
- Locoregional disease control in metastatic melanoma: Exploratory analysis from phase 2 testing of intralesional rose bengal (2013) (4)
- Recombinant IL-21 in combination with sorafenib: Preliminary results from a phase I/II study in patients with metastatic renal cell cancer (2007) (4)
- Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: study protocol (2020) (4)
- The Southampton teaching triad: an audit of operative surgical instruction. (1990) (4)
- Mucosal Hyperplasia in Infant With Jejunal Web (2013) (4)
- Prognostic impact of cancer-testis antigen expression in primary cutaneous melanoma. (2009) (4)
- Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics. (2022) (4)
- Developments in surgical oncology — past, present and future trends (1991) (4)
- The problems associated with conversion from azathioprine and prednisolone to cyclosporine. (1985) (4)
- Primary oesophageal melanoma - a case report (2014) (4)
- Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard (2014) (4)
- Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. (2020) (4)
- The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma (2019) (4)
- Donation and retrieval of cadaveric organs in Australia : Accepting the challenge (1993) (4)
- Surgical excision margins for primary cutaneous melanoma (2011) (4)
- Clinical outcomes following surgical treatment of lentigo maligna of the head and neck. (2020) (4)
- Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites (2022) (4)
- Isolated limb infusion for melanoma: Results of an elective double infusion protocol (1995) (4)
- Temporary elevation of serum transaminases after pediatric intestinal transplantation: incidence and clinical correlation in multivisceral transplant vs isolated intestinal transplant. (2006) (4)
- [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion]. (2009) (4)
- Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma–Mass Spectrometry (2008) (4)
- Impact of Increased Body Weight on Acute Toxicity and Outcome of Autologous Stem Cell Transplantation for Non-Hodgkin’s Lymphoma: A Southwest Oncology Group Analysis. (2004) (4)
- Liver resection for neoplasm. (1981) (4)
- Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II) (2022) (4)
- Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition (2020) (4)
- Who detects the first recurrence in stage I cutaneous malignant melanoma: patient or doctor? 156 (1993) (4)
- Sentinel node biopsy is now part of routine staging in patients with clinically localized melanoma (2014) (4)
- Sentinel-lymph node biopsy in breast cancer (1998) (4)
- Intra-operative autologous blood transfusion (IAT) - can we do better? (1999) (4)
- Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study (2022) (4)
- Continuing and new roles for surgery in the management of patients with stage IV melanoma (2018) (4)
- The prognostic significance of microsatellites in cutaneous melanoma (2020) (4)
- Management of pigmented skin lesions during pregnancy. (2019) (4)
- A review of 567 cases of brain metastases from malignant melanoma: 141 (1993) (4)
- More on Adjuvant Therapy in Resected Melanoma. (2018) (4)
- Vascular surgery II (1992) (4)
- Autotransfusion of shed mediastinal blood. (1989) (4)
- MSLT-I—response of clinical trial investigators (2014) (4)
- CO12. Chemoablation of metastatic melanoma with intralesional PV-10 (2011) (3)
- Detection and grading of femorodistal vein graft stenoses: duplex velocity measurements compared with angiography. (1989) (3)
- Treatment of in-transit melanoma metastases using intralesional PV-10 (2021) (3)
- Radioguided Sentinel Lymph Node Mapping and Biopsy in Cutaneous Melanoma (2016) (3)
- Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients. (2017) (3)
- Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome (2022) (3)
- Hepatocellular Carcinoma in a Child With Chronic Hepatitis C and α-1 Antitrypsin Heterozygosity. (2017) (3)
- Human kidney preservation with University of Wisconsin solution: an initial report of the Australian experience. (1992) (3)
- Comprehensive molecular profiling of metastatic melanoma to predict response to monotherapy and combination immunotherapy. (2019) (3)
- Decision-making in 100 patients referred to the Australian National Liver Transplantation Unit. (1989) (3)
- Letter re: Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma: A multicenter experience. (2019) (3)
- Cellular blue naevus involving the urinary bladder. (2012) (3)
- Is iliac lymph node dissection of value?: 163 (1997) (3)
- Impact of genomics on the surgical management of melanoma (2018) (3)
- Reply to M. Perier-Muzet et al. (2014) (3)
- Predicting Sentinel Node Status in Patients With Melanoma: Does Gene Expression Profiling Improve Accuracy? (2020) (3)
- Current status of diagnosis of small bowel rejection. (1998) (3)
- Surgical management of conjunctival melanomas. (1999) (3)
- The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma (2022) (3)
- Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection (2022) (3)
- Chapter 33 – Cancer in Dialysis and Renal Transplant Patients (2008) (3)
- Automated next-generation profiling of genomic alterations in human cancers (2022) (3)
- Donation and retrieval of cadaveric organs in Australia (1993) (3)
- Multi-trait genetic analysis identifies auto-immune loci associated with cutaneous melanoma. (2021) (3)
- Sentinel node biopsy is more accurate than elective lymph node dissection in determining the regional node status of patients with cutaneous melanoma (2004) (3)
- Hepatic transplantation for hepatitis B-associated liver disease. (1992) (3)
- Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life (2019) (3)
- Textbook of Melanoma : Pathology, Diagnosis and Management (2003) (3)
- Subclavian Artery Aneurysm: The Role of Magnetic Resonance Imaging (1994) (3)
- Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms (2022) (3)
- MAGE-A3 expression in patients screened for the DERMA trial: A phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanoma. (2012) (3)
- The role of nuclear medicine in liver transplantation (1988) (3)
- The impact of multiple primary cutaneous melanomas on survival of 2,942 patients with metastatic melanoma. (2010) (3)
- Regressing metastatic melanoma and vitiligo‐like depigmentation in an Indigenous Australian (2010) (3)
- Primary dermal melanoma: clinical behaviour, prognosis and treatment. (2020) (3)
- Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients. (2019) (3)
- Chemoablation of melanoma with intralesional rose bengal (PV-10). (2009) (3)
- Retrieval of organs for transplantation: experience of the Australian National Liver Transplantation Unit (1996) (3)
- Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations (2021) (3)
- Pigmented Paget's disease of the nipple mistaken for melanoma in situ: a diagnostic pitfall for the unwary. (2018) (3)
- In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma (2010) (2)
- Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management. (2020) (2)
- Doctors' recognition and management of melanoma patients' risk: An Australian population-based study. (2016) (2)
- Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease (2019) (2)
- Biopsy of the Sentinel Lymph Node (2020) (2)
- Management of Regional Lymph Nodes in Patients with Merkel Cell Carcinoma Following a Positive Sentinel Node Biopsy: Less May be More, But is Either Enough? (2018) (2)
- Predicting response to IL-2 therapy for metastatic melanoma (2009) (2)
- Primary pulmonary melanoma (2003) (2)
- The rational use of homologous blood in elective surgery. (1992) (2)
- BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting (2021) (2)
- Pigmented epithelioid melanocytoma. Authors' reply (2004) (2)
- Management of pigmented skin lesions in childhood and adolescence. (2019) (2)
- Use of Antibody Microarrays in the Analysis of Inflammation, Autoimmunity, Viral Infection, and Cancer Metastases (2008) (2)
- Isolated Imunohistochemistry-positive Cells Without Morphologic Characteristics of Melanoma Should Not Result in Designation as a Positive Sentinel Lymph Node According to the AJCC 8th Edition Staging System. (2019) (2)
- Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta‐analysis (2022) (2)
- Punch biopsy of melanoma causing tumour cell implantation: Another peril of utilising partial biopsies for melanocytic tumours (2015) (2)
- Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal (2017) (2)
- Epigenetic pro fi ling for the molecular classi fi cation of metastatic brain tumors (2019) (2)
- Spiritual Maturity: An Exploratory Study and Model for Social Work Practice (2008) (2)
- Redefining Disease and Pharmaceutical Targets Through Molecular Definitions and Personalized Medicine (2010) (2)
- Germline variants are associated with increased primary melanoma tumor thickness at diagnosis (2020) (2)
- INTESTINAL TRANSPLANTATION IN CHILDREN – A SINGLE CENTER EXPERIENCE OVER 100 CASES (2004) (2)
- LETTERS TO THE EDITOR (2006) (2)
- CYCLOSPORIN A IN OLIGURIC RENAL TRANSPLANT RECIPIENTS (1981) (2)
- When is surgery for metastatic melanoma still the most appropriate treatment option? (2018) (2)
- Evidence-Based Follow-Up Schedules After Primary Cancer Treatment (2020) (2)
- Measurement of the potential for cadaveric organ retrieval in New South Wales, Australia. (1993) (2)
- Multidisciplinary care of cancer patients: a passing fad or here to stay? (2019) (2)
- The role of regional chemotherapy for advanced limb melanoma in the era of potentially effective systemic therapies (2021) (2)
- The European Working Time Directive and vascular surgery: planning to deal with urgent referrals. (2004) (2)
- Liver transplantation: an Australian experience. (1990) (2)
- Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study (2020) (2)
- Unintentional 4-Aminopyridine Overdose in a Multiple Sclerosis Patient (2013) (2)
- Re: "Time to Reconsider the Role of Sentinel Lymph Node Biopsy in Melanoma". (2019) (2)
- Preliminary experience of angioscopy in femorodistal bypass. (1993) (2)
- The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultra-thick melanomas (≥15mm in thickness). (2022) (2)
- Prognostic value of sentinel lymph node biopsy (2007) (2)
- Multivariate prognostic model for patients with thick cutaneous melanoma: Results of a large multi-institutional study (2004) (2)
- Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting (2022) (2)
- Completion lymph node dissection in melanoma patients with positive sentinel lymph nodes. (2013) (2)
- Points: Non-operative management of perianeurysmal fibrosis (1988) (2)
- Magnetic resonance spectroscopy in the management of melanoma (2005) (1)
- wild-type melanomas have a high mutation load correlating with histological and molecular signatures of UV damage (2013) (1)
- 20 Prophylactic isolated limb perfusion for high risk (≥ 1.5 mm) limb melanoma phase III trial from EORTC and WHO Melanoma Group (1999) (1)
- 17 – Cutaneous Metastases (2010) (1)
- Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases (2022) (1)
- Sentinel lymph node biopsy remains the most accurate method of obtaining staging and prognostic information for patients with primary cutaneous melanomas (2018) (1)
- ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in MSLT-II (2022) (1)
- Comment on "Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma". (2019) (1)
- Recent advances and important issues in melanoma pathology: an update for oncologists (2012) (1)
- Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas. (2021) (1)
- MP14-08 A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN) (2021) (1)
- 23. Primary Melanoma of the Lung (2012) (1)
- Lone Stent-Graft Treatment of Symptomatic Gluteal Artery Aneurysm. (2016) (1)
- Time for comprehensive reporting of MSLT-I – Authors' reply (2006) (1)
- ASO Author Reflections: Limited Surgery Plus Radiotherapy for Melanoma Patients with Cervical Node Metastases (2018) (1)
- Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study To Evaluate The Safety and Tolerability Of Intravenous Infusion Of SNS01-T In Patients With Relapsed Or Refractory Multiple Myeloma, Mantle Cell Lymphoma, Or Diffuse Large B Cell Lymphoma (2013) (1)
- Lymphatic Drainage in Patients with Primary Cutaneous Melanoma - the Role of Lymphoscintigraphy in Sentinel Lymph Node Biopsy (2006) (1)
- Prognostic F actors A nalysis o f 1 7,600 M elanoma P atients: Validation o f t he A merican J oint C ommittee o n C ancer Melanoma S taging S ystem (2001) (1)
- Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients. (2022) (1)
- Single molecule RNA sequencing of formalin-fixed paraffin-embedded tissue derived from patients with lung cancer. (2011) (1)
- Abstract 913: Defining melanoma patients unresponsive to single agent anti-PD-1 therapy but responsive to combination anti-PD-1 + anti-CTLA-4 therapy (2020) (1)
- History of Melanoma (2018) (1)
- Isolated Limb Infusion for Recurrent and Locally Metastatic Limb Melanoma (2018) (1)
- Abstract 2761: CODEX highly multiplex image mapping to CITEseq datasets reveal the spatial dynamics of the TME during the development of acquired resistant in immunotherapy treated melanoma (2021) (1)
- INTESTINAL TRANSPLANTATION FOR CHILDREN AT THE UNIVERSITY OF MIAMI ‐ FIVE YEAR EXPERIENCE.: Abstract# 744 Poster Board #‐Session: P1‐III (2000) (1)
- Making sense of the melanoma information tsunami. (2014) (1)
- ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges (2019) (1)
- Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). (2022) (1)
- Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). (2022) (1)
- ASO Visual Abstract: Evaluation of Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International Multicenter Study (2022) (1)
- 27. Pathological features of metastases from primary cutaneous desmoplastic melanoma (2011) (1)
- Steroid Use Increases the Risk of Overweight and Obesity in Children With Inflammatory Bowel Disease: P‐146 (2012) (1)
- The Clinical Value of Sentinel Lymph Node Biopsy In Melanoma Staging, Regional Disease Control, and Survival (2015) (1)
- 'No touch' donor hepatectomy, oxygenated 'extracellular' preservation fluids, and arterialization of the portal vein for liver transplantation (1988) (1)
- Australian National Multi-Center Study of Isolated Limb Infusion Chemotherapy for Extremity Melanoma (2014) (1)
- Axillary and Epitrochlear Lymph Node Dissection for Melanoma (2020) (1)
- In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma (2009) (1)
- Cross-Platform Omics Prediction procedure: a game changer for implementing precision medicine in patients with stage-III melanoma (2020) (1)
- First Eastern European experience of isolated limb infusion for in-transit metastatic melanoma confined to the limb: Is it still an effective treatment option in the modern era? (2019) (1)
- Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia (2019) (1)
- Lymphoscintigraphy in Patients with Melanoma (2018) (1)
- Groin and pelvic dissection for melanoma (2003) (1)
- Regarding complications following completion lymphadenectomy. (2017) (1)
- The impact of socioeconomic status on melanoma clinical trial participation: an observational cohort study from Australia. (2014) (1)
- The clinical importance of lymphoscintigraphy for sentinel lymph node biopsy in melanoma and breast cancer (2006) (1)
- Research Agenda for Pediatric Gastroenterology, Hepatology and Nutrition: Developmental Physiology and Pathophysiology: Report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition for the Children's Digestive Health and Nutrition Foundation (2002) (1)
- Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastases (2012) (1)
- Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases (2017) (1)
- Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study (2018) (1)
- The Allen Brown shunt: a useful option for vascular access. (1991) (1)
- Frequency and duration of complete remission after therapeutic isolated limb perfusion for melanoma: 114 (1997) (1)
- EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. (2015) (1)
- Regarding pedunculated malignant melanoma. (2000) (1)
- Abstract 2968: Exome sequencing of desmoplastic melanoma reveals recurrent NFKBIE promoter mutations and diverse MAPK/PI3K pathway activating mutations (2015) (1)
- Granulocyte-macrophage colony stimulating factor (GM-CSF, sargramostim) as adjuvant therapy of melanoma (2008) (1)
- Disparity in the risk stratification of major surgery. (2008) (1)
- Can the demand for cadaver kidneys be met? (1992) (1)
- International Multi-Center Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in the Octogenarian Patient (2020) (1)
- Training Vascular Surgeons and Protecting the Patients' Interests (1999) (1)
- Current strategies for the surgical management of melanoma (2005) (1)
- Metastatic disease in the internal mammary lymph nodes has an adverse effect on patient prognosis and survival, regardless of axillary node status. (2000) (1)
- Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. (2021) (1)
- Superior survival of young women with malignant melanoma. (1999) (1)
- Melanomas in children and adolescents: Clinicopathologic features and survival outcomes. (2022) (1)
- Outcome in 846 cutaneous melanoma patients from a single center after negative sentinel node biopsy (2006) (1)
- Has the advent of modern adjuvant systemic therapy for melanoma rendered sentinel node biopsy unnecessary? (2023) (1)
- Regarding amelanotic melanomas. (1999) (1)
- Venous thrombosis following segmental pancreatic transplantation using latex duct occlusion. (1985) (1)
- Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma (2022) (1)
- Organ transplantation and outcomes in patients with a past history of melanoma: A systematic review and meta‐analysis (2021) (1)
- Kidney transplantation and seat belt legislation. (1983) (1)
- All blood counts: a manual for blood conservation and patient blood management (2015) (1)
- Re: Sydney Melanoma Unit patients and Multicenter Selective Lymphadenectomy Trial protocol (2006) (1)
- Isolated limb infusion with cytotoxic agents for recurrent limb melanoma: results of 120 procedures (1997) (1)
- Representativeness of initial skin biopsies showing pure desmoplastic melanoma: implications for management. (2023) (1)
- The intriguing association between smoking and reduced melanoma risk (2019) (1)
- Validity of reported melanoma incidence rates in New Zealand (2004) (1)
- ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas (2018) (1)
- Obesity is associated with altered tumor metabolism in metastatic melanoma. (2022) (1)
- Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma. (2022) (1)
- Recombinant activated factor VII and aortic surgery. (2013) (1)
- In reply [10] (2007) (1)
- Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
- Hypoxia controls the glycome signature and galectin-8 - ligand axis to promote pro-tumorigenic properties of metastatic melanoma. (2022) (1)
- Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis (2018) (1)
- First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality (2015) (1)
- Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma. (2022) (1)
- INTESTINAL TRANSPLANTATION FOR SHORT GUT SYNDROME SECONDARY TO GASTROSCHISIS (2004) (1)
- Surgical Technique for Open Inguinal Lymphadenectomy (2018) (1)
- Cutaneous melanoma/Authors' reply (2007) (0)
- Post‐Transplant Management (2009) (0)
- The role of CD16+ NK cells and CD16+ CD56– cells in predicting response to anti-PD-1 therapy (2018) (0)
- Mutational analysis of undifferentiated melanoma (2020) (0)
- Human Cancer Biology BRAF / NRAS Wild-Type Melanomas Have a High Mutation LoadCorrelatingwith Histologic andMolecular Signatures of UV Damage (2013) (0)
- Surgical management of melanoma: have we made any progress in 100 years? (2006) (0)
- BLOOD PRESSURE RESPONSES TO MARITAL SUPPORT (1999) (0)
- INTESTINAL TRANSPLANTATION FOR NECROTIZING ENTEROCOLITIS. (1999) (0)
- Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi (2022) (0)
- Isolated Limb Infusion of the Extremity (2015) (0)
- Abstract A154: Flow cytometric analysis of immune responses in the melanoma tissue biopsies before or during anti-PD1 immunotherapy (2019) (0)
- Australia's most common malignancy: Skin cancer in focus (2012) (0)
- We Need a Trial to Evaluate Whether Patients with Involved Inguinal Lymph Nodes Should Have Inguinal or Ilio-Inguinal Lymphadenectomy; An Overview of the Proposed Trial Anzmtg 01.12 Eagle Fm Protocol (2013) (0)
- Expression of cancer-testis antigens in late stage melanoma is associated with high FoxP3 expression in tumour infiltrating lymphocytes in early stage disease (2010) (0)
- Can histologic parameters of melanoma metastases in sentinel lymph nodes reliably select patients who can be safely spared completion lymph node dissection? (2010) (0)
- Improving Screening of Vitamin D Status in Pediatric Inflammatory Bowel Disease Patients (2017) (0)
- Popliteal lymph node involvement by metastatic melanoma: 382 (1997) (0)
- Lower Lip Reconstruction Revisited - Technical Solutions to Prevent Oral Incontinence and Maximize Vermilion Anterior Projection. (2020) (0)
- MP14-13 EVALUATING BASELINE AND CHANGE IN BODY COMPOSITION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WITH FRONT-LINE SYSTEMIC THERAPY: IMPLICATIONS FOR ADVERSE EVENTS AND OVERALL SURVIVAL (2021) (0)
- Whole-body 18F-Flurodeoxyglucose positron emission tomography in preoperative assessment of colorectal liver metastases. (Abstract) (1995) (0)
- Effect of Acute Normovolemic Hemodilution on Blood Coagulation (1994) (0)
- P-29. Leucocytic Infiltration of the Endometrium (1998) (0)
- A Confusing Message Will Not Improve the Detection of Melanoma—Reply (2007) (0)
- MammaryLymphoscintigraphyin Breast Cancer (1995) (0)
- Skin cancer: non-melanoma (2016) (0)
- 23. Prevalence and expression profile of immune checkpoint receptors in untreated human melanoma (2019) (0)
- Adjuvant nodal irradiation in melanoma – Authors' reply (2012) (0)
- 24. The prognostic value of mitotic rate in recurrent melanoma (2011) (0)
- MP14-19 SALVAGE IMMUNE CHECKPOINT INHIBITOR (IO) PLUS TYROSINE KINASE INHIBITOR (TKI) COMBINATION THERAPY FOR METASTATIC RENAL CELL CARCINOMA (mRCC) (2021) (0)
- MSLT-I: Comparing apples to antelopes--Reply. (2015) (0)
- 33. Snore (non-Sentinel Node Risk score): a system for accurately stratifying risk of non-sentinel node positivity in cutaneous melanoma patients with positive sentinel lymph nodes (2011) (0)
- Communication of the melanoma diagnosis: 232 (1997) (0)
- Neoadjuvant dabrafenib and trametinib (D+T) for stage III melanoma: Long-term results from the NeoCombi trial. (2022) (0)
- SNS01-T Exhibits Significant Anti-Tumoral Activity In Models Of Multiple Myeloma and Non-Hodgkins B Cell Lymphoma and Induces Cell Death In Malignant But Not Normal B Cells (2013) (0)
- Fast-Growing and Slow-Growing Melanomas—Reply (2007) (0)
- Quality of renal allografts obtained from multiple organ donors. (1989) (0)
- Surgical management of primary melanoma: reconstruction techniques after wide excision (2003) (0)
- Interferon alpha-2b and thalidomide in previously treated patients with disseminated malignant melanoma: SWOG 0026 (2004) (0)
- The Sydney Melanoma Unit experience with acral lentiginous melanoma: 384 (1997) (0)
- Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
- ENDOSCOPIC ASSESSMENT OF REJECTION IN PEDIATRIC INTESTINAL TRANSPLANT PATIENTS (1998) (0)
- P47 Modified blalock-taussig shunts versus ductal stenting in duct dependent cyanotic congenital heart defects (2016) (0)
- BRAF Inhibitor Treatment BRAF-Mutant Melanoma Patients during Growth Factor Serum Levels in Dynamics of Chemokine , Cytokine , and (2014) (0)
- Molecular motor associated lipids as potential probes for neuronal transport in retinal ganglion cells (2014) (0)
- Same‐day or next‐day sentinel node biopsy after lymphoscintigraphy for melanoma using 99mTc‐labelled antimony sulphide colloid (2020) (0)
- PD-L1 expression, immune cell correlates, and PD-1+ lymphocytes in sentinel lymph node positive melanoma patients: Implications for adjuvant PD-1 clinical trials. (2015) (0)
- P-28. Submucous Fibroid in the Prediction of the Bleeding Pattern in Postmenopausal Women on Trimegestone-Based Sequential HRT Regimen (1998) (0)
- Will the liver fit?: A method of predicting donor liver size for orthotropic liver transplantation (1989) (0)
- Positron emission tomography for staging and surveillance in gastric carcinoma (Abstract) (1995) (0)
- A 14‐Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma (2018) (0)
- The worse survival outcomes reported for melanoma patients having sentinel node biopsy after lymphoscintigraphy the previous day do not appear to be due to overnight migration of Tc99m-nanocolloid tracer. (2021) (0)
- Melanoma recurrence after lymphatic mapping and negative sentinel lymph node biopsy: 383 (1997) (0)
- 31. Prognostic importance of the extent of ulceration of clinically localised cutaneous melanoma (2011) (0)
- Sa1999 Characteristics of Racially Diverse Pediatric Inflammatory Bowel Disease (IBD) Population (2012) (0)
- Publisher Correction: Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence (2020) (0)
- Chapter 5 – Brain Metastases from Melanoma (2016) (0)
- Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma (2009) (0)
- New treatment paradigms for clinically apparent metastatic melanoma in regional lymph nodes (2019) (0)
- Treatment of in-transit Merkel cell carcinoma by isolated limb infusion with cytotoxic drugs (2022) (0)
- Genomic Landscape of Patient-matched Tumor and Circulating Cell-free DNA in Metastatic Melanoma (2019) (0)
- Desmoplastic Melanoma (2019) (0)
- Assessment of the prognostic role of regression in primary cutaneous melanoma (2020) (0)
- EFFECT OF HLA-DR AND CLASS I CREG MATCHING CARDIAC TRANSPLANTS(TNX): AN ANALYSIS OF ACCESS AND OUTCOME (1998) (0)
- RT11: Targeted Alpha Therapy for Melanoma: From Bench to Bedside (2001) (0)
- The expression of metalloproteinases in the endometrium of postmenopausal women treated with trimegestone‐based hormone replacement therapy compared to the natural cycle (2000) (0)
- Surgical treatment of intra-abdominal melanoma metastases: 385 (1997) (0)
- Increased expression of Mcl-1 and Bcl-XL and decreased expression of Bcl-2 associated with melanoma progression and transcription factors (2006) (0)
- A History of Melanoma: From Hunter to Morton (2020) (0)
- Abstract 3246: Dynamics of T-cell checkpoint receptor profiles during melanoma progression (2019) (0)
- Direct lymphatic drainage from cutaneous melanomas of the back to para-aortic and mediastinal lymph nodes demonstrated by lymphoscintigraphy: 307 (1993) (0)
- Melanoma guide for GPs (2012) (0)
- Correct identification of a sentinel node postselective lymphadenectomy using antimony levels. (2008) (0)
- Genomic alterations in metastatic basal cell carcinoma (2020) (0)
- Sentinel node biopsy improves regional node staging in melanoma patients (2001) (0)
- What were you doing when your graft blocked (1998) (0)
- Surgical Management of Distant Melanoma Metastases (2019) (0)
- Long-term survival and disease regression after adrenalectomy for adrenal metastases from melanoma. (2004) (0)
- Preliminary feasibility data from the Melanoma Margins Trial (MelMarT) pilot study: Australian and New Zealand Melanoma Trials Group (ANZMTG) study 03.12 (2016) (0)
- Increased Vascularity in Norethisterone-based Hormone Replacement Therapy Compared to the Natural Cycle: P-119. (1999) (0)
- ASO Author Reflections: Ultrasound Assessment of the Lymphatic Drainage Area in Melanoma Patients With In-Transit Metastases (2020) (0)
- Vascular surgery — current questions. A. A. B. Burros D'Sa, P. R. F. Bell, S. G. Darke, P. L. Harris (eds). 170 × 240 mm. Pp. 250. Illustrated. 1991. Oxford: Butterworth‐Heinemann. £49.50 (1992) (0)
- Sentinel node biopsy for breast cancer: then and now (2012) (0)
- ANALYSIS OF CAUSES OF GRAFT FAILURE AFTER CADAVERIC KIDNEY TRANSPLANTATION COMPARED TO LIVING UNRELATED DONOR KIDNEY TRANSPLANTATION (1999) (0)
- ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases (2022) (0)
- Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible (2014) (0)
- Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. (2021) (0)
- 32. Sentinel lymph node biopsy in patients with thin melanoma (2011) (0)
- LNK suppresses interferon signaling in melanoma (2019) (0)
- Prognostic Factors and Staging of Melanoma (2002) (0)
- Chapter 5 Isolated Limb Infusion of the Extremity (2015) (0)
- Management of Bleeding Disorders in Surgical Practice. C. D. Forbes and A. Cuschieri (eds). 240 × 157 mm. Pp. 387. Illustrated. 1993. Oxford: Blackwell Scientific. £49–50. (1994) (0)
- Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis (2019) (0)
- Melanoma of the urogenital tract (2003) (0)
- Isolated limb infusion with cytotoxic agents: a simple, effective alternative to isolated limb perfusion for recurrent melanoma (1997) (0)
- Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach (2023) (0)
- Reflection and Reaction (2005) (0)
- Study of the delays in reviewing plain radiographs on the acute surgical take in a district general hospital (2012) (0)
- Evaluating and Embracing Modern Imaging Technology to Guide Sentinel Node Biopsy for Melanoma (2022) (0)
- Specialized Cancer Procedures and Surgery (2014) (0)
- Re: NM patients and SN. (2007) (0)
- Donor liver procurement: experience with 200 donors at the Australian National Liver Transplantation Unit, Sydney. (1994) (0)
- Abstract 2609: Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality (2021) (0)
- General practitioners’ involvement in diagnosing, treating and referring patients with suspected or confirmed primary cutaneous melanoma: a qualitative study (2019) (0)
- Lymphatic mapping and sentinel lymph node biopsy: the concept (2003) (0)
- 34. Association of histological features of metastatic melanoma in sentinel lymph nodes with lymph node recurrence, distant metastasis and survival (2011) (0)
- Is resection of pulmonary metastases from malignant melanoma worthwhile?: 387 (1993) (0)
- Association between excision margins and local recurrence in 1407 patients with primary in situ melanomas (2022) (0)
- Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al. (2021) (0)
- The importance of an informed consent interview in successful patient recruitment into clinical trials: 380 (1997) (0)
- Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine (2022) (0)
- Analysis of clinical and molecular profiles of patients with innate resistance to ANTI-PD-1 +/- ANTI-CTLA-4 immunotherapy in metastatic melanoma (2021) (0)
- EJVES Extra AbstractOcclusion of the Profunda Femoris Artery in Competitive Cyclists (2010) (0)
- The organisation of cadaver multiple organ donation: a critical issue for establishing and maintaining successful transplantation programs. (1992) (0)
- Mo1966 Diagnostic Yield of Laboratory Evaluation of Elevated Alanine Aminotransferase Levels in an Urban Obese Pediatric Population (2012) (0)
- Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes (2022) (0)
- Six of the Best, Vascular 23–28 (2003) (0)
- Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting (2022) (0)
- Donor factors and liver transplantation. (1992) (0)
- Preoperative induction regional chemotherapy for gastric carcinoma (1995) (0)
- Hepatic transplantation for hepapitis B-associated liver disease : IX th Scientific meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, April 10-12, 1991 (1992) (0)
- Abstract 5701: Predictive biomarker models of immunotherapy response in patients with metastatic melanoma: genomic, transcriptomic, and immune profiles from the Personalised Immunotherapy Program (PIP) (2023) (0)
- John Moores Painting Prize 2010 (2010) (0)
- Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D) (2014) (0)
- Abstract 2206: Proteome phenotype of stage III metastatic melanoma and response to MEK inhibition (2017) (0)
- 17. Peritoneal epithelioid mesothelioma in a patient with metastatic melanoma - an association seen in BAP1 mutations (2014) (0)
- No reply received Heparin During Aneurysm Repair (2005) (0)
- athologic examination of sentinel lymph nodes from elanoma patients (2008) (0)
- Amputation. Surgical practice and patient management. G. Murdoch and A. Bennett Wilson Jr (eds). 257 × 192 mm. Pp. 391. Illustrated. 1996. Oxford: Butterworth-Heinemann. £85 (1997) (0)
- Response to ‘Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable’ (2022) (0)
- ASO Visual Abstract: Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma (2022) (0)
- Autotransfusion of shed mediatinal blood. Reply (1989) (0)
- Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC) (2022) (0)
- 805P Predicting recurrence-free survival for patients with stage II melanoma: A validated tool to guide selection for adjuvant systemic therapy (2022) (0)
- Biomarkers of response and resistance to combined anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients utilising multiplex immunofluorescence (2018) (0)
- Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
- Complex iliac and bilateral common femoral artery aneurysms: a novel hybrid procedure. (2006) (0)
- Radiation in the Management of Primary and Regional Merkel Cell Carcinoma (2010) (0)
- Primary invasive melanoma on the head and neck: Distribution, ultraviolet exposure and histological subtype in 1,298 Australian patients (2007) (0)
- Epitrochlear lymph nodes as a site of melanoma metastasis: 381 (1997) (0)
- Hepatic surgery for metastatic melanoma (2003) (0)
- A Selective Approach to Resection of Cystic Lesions of the Pancreas : Results From 539 Consecutive Patients (2007) (0)
- Breast Cancer and Melanoma Metastases in Regional Lymph Nodes Identified Using In Vivo Proton Magnetic Resonance Spectroscopy at 3 Tesla (2006) (0)
- Appropriate excision margins for cutaneous melanomas (2019) (0)
- Phase I/II open-label, multiple-dose, dose-escalation study to evaluate the safety and tolerability of SNS01T administered by intravenous infusion in patients with relapsed or refractory multiple myeloma. (2012) (0)
- Risk of developing a second primary melanoma after a first primary melanoma in a population-based Australian cohort. (2023) (0)
- Epigenetic profiling for the molecular classification of metastatic brain tumors (2018) (0)
- Detection of first recurrences in cutaneous melanoma patients: A prospective study. (2004) (0)
- Combination Therapy with Novel Nanoparticle, SNS01-T, and Lenalidomide Triggers Synergistic Cytotoxicity in Vitro and in Vivo in Multiple Myeloma and Mantle Cell Lymphoma (2012) (0)
- Melanoma management in 2007. -letter- (2007) (0)
- Elevated macro creatine kinase type 2 in serum reflecting tumour cell breakdown after 'stop-flow' aortic chemotherapy (1994) (0)
- Evidence that Chinese herbal medicine is of no advantage in murine fetal pancreatic transplants. (1989) (0)
- MO-0152 Hypofractionated versus conventional adjuvant radiotherapy for lymph node metastases of melanoma (2022) (0)
- Is lentigo meligna melanoma a separate disease entity?: 376 (1997) (0)
- An airflow system for management of Botrytis cinerea on lisianthus (2004) (0)
- ASO Author Reflections: The Clinical Relevance of Sentinel Nodes in Minor Lymph Node Fields Such as the Triangular Intermuscular Space in Patients with Melanoma. (2023) (0)
- Surgery offers no more than medical treatment in the management of transient ischaemic attack. (1990) (0)
- Molecular Genomic Profiling of Melanocytic Nevi (2019) (0)
- Transcriptomic and immunophenotypic profiles of melanoma tissue from patients (pts) treated with anti-PD-1 +/- ipilimumab to define mechanisms of response and resistance. (2018) (0)
- Radiation Therapy for Melanoma Brain Metastases: A Systematic Review (2022) (0)
- ASO Author Reflections: Surgical Resection May Improve the Outcome for Patients with Residual Metastatic Melanoma When Modern Systemic Therapies Have Not Achieved Complete Disease Control (2021) (0)
- Drug dosage calculation for isolated limb perfusion (ILP) by perfusion circuit volume (PCV) measurements using indocyanine green (ICG): 346 (1993) (0)
- Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas (2021) (0)
- Issue Information ‐ TOC (2018) (0)
- Regulation of matrix metalloproteinases by trimegestone in stromal cell culture compared to progesterone (2000) (0)
- Abstract A04: Analysis of molecular and immune features that correlate with serum lactate dehydrogenase (LDH) levels in patients (pts) with metastatic melanoma (2020) (0)
- Abstract 81: The association between melanoma liver metastases (mets) and the systemic anti-tumor immune profile (2023) (0)
- Differences in immune profiles of metastatic melanoma patients treated with anti-CTLA-4 and anti-PD-1 combined immunotherapy. (2017) (0)
- Distinct Immune Cell Popu lations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1 / Anti-CTLA-4 Combined Therapy Graphical (2019) (0)
- Quantifying the additional prognostic value of sentinel lymph node status over established clinicopathologic primary tumor features for predicting survival outcomes in melanoma patients. (2020) (0)
- Overtransfusion in surgical management: do we practise what we proach? (1999) (0)
- Benign blue naevi involving lymph nodes: A case series with accompanying molecular data and long term follow-up confirms clinical behaviour (2020) (0)
- Long-term survival and disease regression after adrenalectomy for adrenal metastases from melanoma (2004) (0)
- Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
- Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes (2022) (0)
- REPLY to MS#JAAD-D-23-00002R1. (2023) (0)
- 1120PSUBGROUP EFFICACY IN PATIENTS RECEIVING INTRALESIONAL ROSE BENGAL TO ALL EXISTING MELANOMA IN PHASE II STUDY PV-10-MM-02. (2014) (0)
- Perioperative blood salvage (2006) (0)
- Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread (2022) (0)
- Assessment of a New Predictive Score for Non-sentinel Node Positivity in Melanoma Patients (2012) (0)
- The effects of trimegestone and norethisterone on the lipid profile in postmenopausal women (2000) (0)
- Melanoma of the lip: 394 (1993) (0)
- Reply to Letter to the Editor “Lymphoedema in the Observation and Biopsy Arms of MSLT-1” by Thomas, J Meirion (ASO-2011-04-0666) (2011) (0)
- Randomized Trial of Whole-Brain Radiation Therapy in Melanoma Brain Metastases: First Interim Analysis (2014) (0)
- 35. Factors predictive of clinical outcomes in patients with thin cutaneous melanoma (2011) (0)
- Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma (2023) (0)
- Has the melanoma information tsunami become a maelstrom? (2017) (0)
- The value of monitoring serum creatine phosphokinase (CPK) following hyperthermic isolated limb perfusion (ILP) for melanoma: 360 (1993) (0)
- Debate: adjuvant whole brain radiotherapy or not? More data is the wiser choice (2016) (0)
- Review Genetic Alterations and Personalized Medicine in Melanoma (2014) (0)
- Reply to I. Satzger et al (2011) (0)
- Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients (2014) (0)
- Melanoma In-situ: A Patterns-of-care Study In New South Wales (nsw) (2008) (0)
- Long-term prospective assessment of quality of life and lymphedema after inguinal or inguinal and pelvic lymphadenectomy for recurrent melanoma in the groin (2016) (0)
- P-16 Regression of melanoma by tumour anti-vascular alpha therapy (2007) (0)
- Who should treat patients with primary melanoma? (2005) (0)
- Lymphatic mapping with lymphoscintigraphy: unusual pathways to watch for (1997) (0)
- Role of elective lymph node dissection in primary malignant melanoma 1.5 mm or thicker of the trunk and limbs without clinical node metastases: 392 (1993) (0)
- 38. INTRALESIONAL MOLECULAR HETEROGENEITY IN A BRAF-MUTANT BRAF INHIBITOR RESISTANT MELANOMA: A CASE ILLUSTRATING THE CHALLENGES FOR PERSONALISED MEDICINE (2013) (0)
- Prednisolone for preschool children presenting with acute wheeze: A multicentre RCT (2017) (0)
- Subungual melanoma: 377 (1997) (0)
- Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival (2021) (0)
- Adjuvant I mmunotherapy o f P atients W ith H igh-Risk Melanoma U sing V accinia V iral L ysates o f M elanoma: Results o f a R andomized T rial (2002) (0)
- Abstract 19 Timeliness to Antibiotics in Pediatric Short Bowel Syndrome Patients With Central Line and Fever in the Emergency Department (2017) (0)
- Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
- Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection. (2023) (0)
- Longitudinal Trajectory of Quality of Life for Patients with Melanoma Brain Metastases: A Secondary Analysis from a Whole Brain Radiotherapy Randomized Clinical Trial (2023) (0)
- P0211 EVERSUN: A phase 2 trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (ANZUP Trial 0901) (2014) (0)
- 112. Safety and efficacy of isolated limb infusion in elderly patients with advanced locoregional melanoma: An Australian multicenter experience (2016) (0)
- New Australian melanoma management guidelines: the patient perspective (2020) (0)
- Plain Language Summary - Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return. (2023) (0)
- Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets (2019) (0)
- Chapter 35 – Cancer in Dialysis and Kidney Transplant Patients (2014) (0)
- External Validation in an Australian Population of the EORTC-DeCOG Nomogram Predicting Recurrence, Distant Metastasis and Overall Mortality in Melanoma Patients with Positive Sentinel Lymph Nodes (2023) (0)
- ABDOMINAL RESECTIONAL SURGERY IN METASTATIC MELANOMA (2007) (0)
- Management of the Parotid/Neck Following a Positive Sentinel Node Biopsy in Patients with Cutaneous Melanoma of the Head and Neck (2019) (0)
- Liver transplantation: the Sydney experience. (1989) (0)
- Prognosis in children with melanoma. (2001) (0)
- The role of intraoperative salvage autotransfusion. (1989) (0)
- Salvage of in situ femoropopliteal and femorotibial saphenous vein bypass with interventional radiology. (1989) (0)
- Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework (2022) (0)
- Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-Reply. (2021) (0)
- Optimising patients' responses to a diagnosis of cancer (2000) (0)
- In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? (2021) (0)
- Trabectedin-induced treatment effects in myxoid liposarcoma refractory to previous chemotherapy (2012) (0)
- THE INFLUENCE OF ACUTE REJECTION ON SERUM CITRULLINE LEVELS AMONG RECIPIENTS OF INTESTINAL AND MULTIVISCERAL TRANSPLANT (2004) (0)
- Quality of Life Following Surgical Excision of Early-Stage Melanoma of the Head and Neck. (2019) (0)
- 26. Lymphoma arising in patients with cutaneous melanoma (2011) (0)
- CROSS-OVER DESIGNS FOR CLINICAL TRIALS. AUTHOR'S REPLY (1991) (0)
- Current management of melanoma patients with a sentinel node metastasis (2020) (0)
- IS CADAVER DONOR A RISK FACTOR FOR ACUTE REJECTION (1999) (0)
- Abstract 5025: Immune expression profiling of MAPK inhibitor resistant tumors based upon mechanisms of resistance (2015) (0)
- Melanoma Prognosis and Staging (2019) (0)
- Reply to A. Mangla and E. Hindié. (2022) (0)
- Tu1165 Discordance Between Thiopurine Methyltransferase Phenotype and Genotype Has Potential Implications in the Initiation Dose of Thiopurine Therapy in Pediatric Patients (2013) (0)
- Do Patients with Stage I/II Melanoma Attend Follow-up Visits as Often as Recommended by Guidelines? (2015) (0)
- P-66.: Endometrial Responses to Trimegestone Based Cyclical Sequential Combined HRT (1997) (0)
- Micrometastatic Melanoma Cell Accumulation in Sentinel Lymph Nodes Containing Dendritic + Long-Term Protective Effect of Mature DC-LAMP (2007) (0)
- Comprar Patient Surveillance After Cancer Treatment | Johnson, Frank E. | 9781603279680 | Springer (2010) (0)
- Approaches to classification and management of histologically ambiguous/ borderline / primary cutaneous melanocytic tumours (2011) (0)
- Chemoablation of cutaneous and subcutaneous metastatic melanoma using PV-1 (2008) (0)
- Treatment of Primary Melanomas (2020) (0)
- ASO Visual Abstract: Survival Outcomes of Salvage Metastasectomy after Failure of Modern-Era Systemic Therapy for Melanoma (2021) (0)
- 49 ORAL Improvement of survival: prognostic factors in relapsed cutaneous melanoma patients (2006) (0)
- 24. Analysis of indoleamine 2,3-dioxygenase expression in longitudinal primary, nodal and distant metastatic melanoma specimens (2019) (0)
- Competing risks analysis with missing cause-of-failure—penalized likelihood estimation of cause-specific Cox models (2022) (0)
- Portosystemic shunting in children with portal hypertension: Its role in the era of endoscopic therapy (1998) (0)
- 62. Angiomatoid fibrous histiocytoma with locoregional lymph node metastasis: A case report (2015) (0)
- 37. ANGIOTROPISM IS AN INDEPENDENT PREDICTOR OF MICROSCOPIC SATELLITES IN PRIMARY CUTANEOUS MELANOMA (2013) (0)
- Isolated limb infusion for the treatment of advanced extremity soft tissue sarcomas (2001) (0)
- 25. The prognostic importance of tumour-infiltrating lymphocyte grade in patients with primary cutaneous melanoma (2011) (0)
- Letter to the Editor (2000) (0)
- Neurocognitive outcomes in a phase-3 randomised trial comparing adjuvant whole brain radiotherapy with observation after local treatment of brain metastases in patients with melanoma (2019) (0)
- Changing patterns of management and improving outcome for patients with brain metastases from cutaneous melanoma: 378 (1997) (0)
- Aetiology of urinary storage symptom syndromes: evaluation of a diet and lifestyle model involving diabetes and obesity in women (2007) (0)
- Consanguineous Siblings with a Novel Mutation in Lipopolysaccharide-Responsive Beige-like Anchor protein (LRBA) (2017) (0)
- EGF receptor signaling pathways shift to the cytoskeleton in differentiating CACO2 cells (2000) (0)
- The Prognostic Significance of Isolated HMB-45 or MelanA – Positive Cells in Melanoma Sentinel Lymph Node In Response : (2008) (0)
- EARLY EXPERIENCE IN AUGMENTING CHIMERISM IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS BY SIMULTANEOUS DONOR BONE MARROW TRANSFUSION (1995) (0)
- P0201 Circulating biomarkers and outcomes in a phase 2 trial of first-line everolimus alternating with sunitinib for advanced renal cell carcinoma (ANZUP 0901—the EVERSUN Trial) (2014) (0)
- O0086 INTESTINAL TRANSPLANTATION FOR CHILDREN-SINGLE CENTER EXPERIENCE OF OVER 100 CHILDREN (2004) (0)
- Models for Predicting Melanoma Outcome (2020) (0)
- Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes. (2022) (0)
- 4. Well-differentiated liposarcoma with unusual vascular component (2012) (0)
- Melanoma of the nose: 380 (1993) (0)
- 3 Tesla Magnetic Resonance (MR) Microimaging of Primary Cutaneous Melanoma (2006) (0)
- Sentinel lymph node biopsy: unresolved questions (2003) (0)
- Radionuclide Therapy in Melanoma (2013) (0)
- Cancer in Dialysis and Transplant Patients (2019) (0)
- Experience of the Sydney Melanoma Unit with mucosal, vulval and glans penis melanomas: 379 (1997) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John F Thompson?
John F Thompson is affiliated with the following schools:
